Navigation Links
Varian's RapidArc Radiotherapy Technology Enables Pioneering Cancer Treatments at Top Dutch Oncology Center

AMSTERDAM, June 18 /PRNewswire-FirstCall/ -- Doctors in the Netherlands have developed new ways to perform radiosurgery on benign acoustic tumors using fast and precise RapidArc(TM) radiotherapy technology from Varian Medical Systems (NYSE: VAR). This is among the findings in several papers published by the team at VU University Medical Center in Amsterdam.

Radiation oncologist Dr. Frank Lagerwaard and his team compared RapidArc with five-arc dynamic conformal arc radiosurgery for vestibular schwannoma, a benign tumor that affects hearing and balance. "Treatment delivery time after patient setup was less than five minutes versus 20 minutes for dynamic conformal arc radiosurgery," says Dr. Lagerwaard. "We found that RapidArc planning was completed within 30 minutes in all cases."

His team found that the RapidArc plans consistently achieved greater conformity and a reduction in areas of low-dose irradiation compared to conventional radiosurgery. "This, together with the benefits of shorter treatment times, allows us to replace our conventional five-arc radiosurgery technique for vestibular schwannomas with RapidArc," added Dr. Lagerwaard.

RapidArc delivers a precise and efficient treatment in single or multiple arcs of the treatment machine around the patient and makes it possible to deliver image-guided intensity-modulated radiotherapy (IMRT) two to eight times faster than is possible with conventional IMRT. Faster treatments allow for greater precision, since there is less chance of patient or tumor movement during treatment delivery and, with less time on the treatment couch, also allow for greater patient comfort.

Cancer patients at VU University Medical Center are treated on two Varian Clinac(R) 2300 CD linear accelerators, a Trilogy(R) linear accelerator, and the Novalis Tx(TM) radiosurgical suite of products, all equipped with RapidArc capability. The clinical team has published scientific papers on early RapidArc treatments, including research comparing RapidArc volumetric modulated arc therapy with conventional IMRT, in peer review journals.

Dr. Ben Slotman, chairman of the hospital's department of radiation oncology, says, "In the past we treated about fifteen percent of patients with IMRT but now use RapidArc for a much larger number of IMRT indications. In addition to standard head and neck and prostate treatments, a range of new indications, such as whole brain radiotherapy with simultaneous boost to multiple brain metastases, pelvic tumors and small lung tumors are now being treated with RapidArc.

"Our experience so far is that RapidArc planning and delivery is considerably faster than alternative methods," added Dr. Slotman. "We are expanding the range of cancers for which we use RapidArc and we believe we can replace our full stereotactic radiotherapy program with RapidArc, just as has happened with IMRT."

Previous findings by Dr. Wilko Verbakel, medical physicist, describing how RapidArc plans could deliver better dose distributions than is achievable with conventional IMRT for head and neck tumors in less than three minutes, has now been substantiated by actual clinical data on more than 100 such patients who have received RapidArc for this indication.

Similarly, a publication in production on small primary lung tumors by Dr. Verbakel describes how clinical delivery of RapidArc for stereotactic radiotherapy could be completed in as little as ten minutes.

In the year since RapidArc was installed at VU University Medical Center, more than 300 cancer patients have been treated using this fast and precise treatment technology.

"VU University Medical Center was one of the first hospitals in the world to introduce RapidArc a year ago and to my knowledge no other hospital has treated as many patients with this technique," says Rolf Staehelin, Varian's European marketing director. "Our sincere congratulations to everyone in the team at VU for making this happen so quickly. They are carrying out some pioneering work that is making radiotherapy treatments faster and more precise."

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America, China, and Europe and in its 79 sales and support offices around the world. For more information, visit

SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Prostate Cancer Patient Receives First RapidArc Radiotherapy Treatment at Major Danish Hospital
2. Cancer Patients in North Wales to Gain Access to Varians RapidArc Radiotherapy Treatments
3. Ajou University Hospital Becomes First in Korea to Treat Using RapidArc(TM) Radiotherapy Technology from Varian Medical Systems
4. RapidArc Radiotherapy Technology Enabling Fast, Accurate Treatments for Pennsylvania Cancer Patients
5. Yashoda Cancer Institute Treats First Patient in India Using RapidArc Radiotherapy Technology
6. New Mexico Doctors Now Treating Brain and Prostate Cancer With RapidArc Radiotherapy Technology
7. Public Cancer Center Becomes First in South-East Asia to Introduce RapidArc Radiotherapy Treatments From Varian Medical Systems
8. Top Belgian Cancer Center Becomes First in Country to Introduce RapidArc Radiotherapy Treatments From Varian Medical Systems
9. A Fast, New Cancer Fighting Tool Is Now Available in the Houston Area: RapidArc(TM) Radiotherapy Technology from Varian Medical Systems
10. Impac Software Announces Clinical Release of RapidArc Support
11. First RapidArc Radiotherapy Treatment in Italy Takes Place at Leading Milan Cancer Center
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... CBD College is proud to ... Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. CBD College is honored ... one of twelve colleges and universities in the state of California make the cut. ...
(Date:11/27/2015)... ... 2015 , ... Indosoft Inc., developer and distributor of the ... LTS (Long Term Support) into its Q-Suite 5.10 product line. , Making the ... a version of Asterisk that will receive not only security fixes, but feature ...
(Date:11/26/2015)... ... November 26, 2015 , ... Somu Sivaramakrishnan announced today that ... Somu now offers travelers, value and care based Travel Services, including exclusive pricing ... well as, cabin upgrades and special amenities such as, shore excursions, discounted fares, ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... opinion process, participated in the 61st annual Employee Benefits Conference. The Employee Benefits ... place Sunday, November 8th through Wednesday, November 11th, 2015. The conference was held ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... aggressive than those found on mammography, according to a study published online in ... cancers not seen on mammography may necessitate a change in treatment. , Breast ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Nederland, November 26, 2015 ... Een nieuwe aanpak combineert immunotherapie met Bremachlorin-photodynamische ... ) --> ...      (Photo: ) ... Universitair Medisch Centrum (LUMC) blijkt ...
(Date:11/26/2015)... 3D bioprinting market is expected ... new report by Grand View Research Inc. Rising prevalence of ... kidney transplantation is expected to boost the market growth, as ... transplantation. --> 3D bioprinting market is expected ... new report by Grand View Research Inc. Rising prevalence of ...
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Cell Surface Testing Market: Supplier Shares, ... their offering.  --> ... the  "2016 Future Horizons and Growth ...
Breaking Medicine Technology: